#selective_serotonin_reuptake_inhibitor
- Baseline depression severity as a predictor of single and combination antidepressant treatment outcome: Results from the CO-MED trial
- Publication bias in systematic reviews
- Early Onset of Selective Serotonin Reuptake Inhibitor Antidepressant Action
- Escitalopram maintenance treatment for prevention of recurrent depression: A randomized, placebo-controlled trial
- Response and remission rates in different subpopulations with major depressive disorder administered venlafaxine, selective serotonin reuptake inhibitors, or placebo